Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

677.28
-10.3303-1.50%
Number of Gainers:70
Number of Losers:73
Number of Flat:10
PE:- -
High:699.38
Open:689.92
Low:677.23
Close:687.61
Volume:352.76M
Turnover:11.79B
Market Cap:466.91B
Float Cap:356.34B

Loading ...

Moderna, Concentrix, Boeing, HPE, Robinhood, Cal-Maine, and More Stocks That Explain Today's Market

Dow Jones
·
Yesterday

Why Robinhood Stock (HOOD) Is Rising Today and What Deutsche Bank Sees Next

TIPRANKS
·
Yesterday

U.S. Stocks on the MOVE-Boeing, Robinhood, Lumentum

Reuters
·
Yesterday

Robinhood price target raised to $140 from $130 at KeyBanc

TIPRANKS
·
Yesterday

UiPath Expands Snowflake Partnership with Two-Way Integration for Governed Data and Automation

Reuters
·
Yesterday

CBOE Global Markets, - Co and Robinhood to Offer KPI Binary Options with no Fees Through End of 2026

THOMSON REUTERS
·
Yesterday

CBOE and Robinhood Announce Planned Launch of New KPI Contracts, Further Expanding Prediction Market Offerings

THOMSON REUTERS
·
Yesterday

KeyBanc Adjusts Price Target on Robinhood Markets to $140 From $130, Keeps Overweight Rating

MT Newswires Live
·
Yesterday

Robinhood up 3% in pre-market after announcing extended trading, AI agents

TIPRANKS
·
Yesterday

Candel Therapeutics Reports Phase 3 Prostate Cancer Biomarker Data Showing Sustained Immune Remodeling After Aglatimagene Treatment

Reuters
·
Yesterday

Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at Astro 2026

THOMSON REUTERS
·
Yesterday

【US Pre-Market】Boeing Gains Nearly 3%, Moderna Slumps Pre-Market as Market Focuses on PCE and Micron Earnings

TradingKey
·
Yesterday

Robinhood Agents Adds Narravance's Viral Stocks Detector

MT Newswires Live
·
Yesterday

Jade Biosciences advances JADE301 toward Phase 1 trial

TIPRANKS
·
Yesterday

Jade Biosciences announces preclinical data of JADE301

TIPRANKS
·
Yesterday

Zeta Global added to Analyst Conviction List at William Blair

TIPRANKS
·
Yesterday

Jade Biosciences to Start Phase 1 Trial of Dermatomyositis Drug Candidate Jade301 in Q4 2026

Reuters
·
Yesterday

Cutia Therapeutics to Launch Up to 30 Million Yuan Share Buyback

MT Newswires Live
·
Yesterday

Jade Biosciences Announces Preclinical Data Characterizing Jade301, a Potentially Best-in-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody in Development for Dermatomyositis, at Eadv 2026

THOMSON REUTERS
·
Yesterday

Jade Biosciences, - Jade301 Shows About 25-Day Half-Life and Predictable Muscle Distribution in Primates

THOMSON REUTERS
·
Yesterday